health

April 28, 2026

Turn on, tune in, cash out … The US right used to fear psychedelics. Now it wants to sell them

Hallucinogens have come a long way from the 60s counterculture to Trump’s White House – propelled by veterans’ lobbying and Silicon Valley capital

Turn on, tune in, cash out … The US right used to fear psychedelics. Now it wants to sell them

TL;DR

  • The US right, once fearful of psychedelics, now supports their use as medical treatments.
  • A presidential executive order aims to accelerate mainstream access to psychedelic-based medical treatments, with a focus on ibogaine.
  • Psychedelics have been rebranded from countercultural symbols to potentially transformative mental health therapies.
  • Scientific research into therapeutic potential has led to support from traditionally conservative communities, including military veterans.
  • The psychedelic market is predicted to grow significantly, attracting substantial investment from Silicon Valley figures.
  • The shift in perception is linked to a worldview that aligns with current Republican administration and tech industry interests.
  • The current movement for psychedelics has transitioned from beatniks and flower power to biohackers and finance capital.

Continue reading the original article